help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, J. L.
Right arrow Articles by Selman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, J. L.
Right arrow Articles by Selman, M.
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 3-5, (2004)
© 2004 American Thoracic Society


Editorial

Respiratory Epithelium in Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis

Spark or Destructive Flame?

Jeffrey L. Myers, M.D.a and Moises Selman, M.D.b

a Mayo Clinic Rochester, Minnesota
b Instituto Nacional de Enfermedades Respiratorias Mexico City, Mexico

Alveolitis, as historically defined, cannot suffice as an explanation for the characteristic pattern of fibrosis and disordered lung architecture that define usual interstitial pneumonia (UIP), the morphologic counterpart of idiopathic pulmonary fibrosis (IPF). UIP/IPF remains a relentlessly progressive lung disorder despite four decades of interest in its pathogenesis and treatment. In an ATS-sponsored consensus statement it was concluded that, "we lack sufficient clinical evidence that any treatment improves survival or the quality of life for patients with IPF" (1). Despite this discouraging conclusion, the authors acknowledged the use of immunosuppressive agents as an entrenched standard of care. The rationale for immunosuppressive therapy, mainly corticosteroids, was rooted in the prevailing hypothesis that inflammation (alveolitis) was key to initiation and maintenance of lung fibrosis linked to empirical observations made at a time that precise diagnostic distinctions did not exist between IPF and its better behaved mimics.

A growing body of evidence indicates that epithelial injury and activation rather than alveolitis are almost certainly the spark responsible for a cascade of events that march inexorably toward fibrosis and honeycomb change in IPF (2). The precise steps that lie between epithelial injury and fibrosis represent a challenging puzzle into which a number of pieces have fallen. Investigators in the 1980s demonstrated features common to seemingly disparate forms of acute and chronic fibrosing lung diseases that could not easily be explained as the consequences of alveolitis (36). These features included epithelial necrosis, denudation and collapse of damaged epithelial basement membranes, migration of fibroblasts/myofibroblasts into air spaces, and accumulation of extracellular matrix resulting in reorganized—and in some patients restored—interstitial/intraalveolar compartments. These events were demonstrated at sites of acute lung injury in UIP/IPF (fibroblast foci), the organizing phase of diffuse alveolar damage in patients with acute interstitial pneumonia, and the intraluminal plugs of fibroblastic tissue (Masson bodies) in cryptogenic organizing pneumonia. The presence of these common events was somewhat surprising given the very different clinical contexts in which they occurred. The conclusion that reparative pathways might dictate differences in the pathogenesis of these conditions was inevitable.

Epithelial cells are key participants in the early and late events that follow acute lung injury. A recent review summarizes abnormal wound repair as a model for understanding IPF (2). Following epithelial injury, surviving and regenerating respiratory epithelium contributes to abnormal antifibrinolytic activity at sites of injury and also elaborates various fibrogenic cytokines/growth factors important in recruitment and phenotypic modulation of fibroblasts and myofibroblasts (2, 7). Fibroblasts, in turn, may amplify alveolar damage by inducing epithelial cell apoptosis (8) and modulating epithelial phenotype through the complex interactions attributed to the "epithelial-mesenchymal trophic unit" (9, 10). Despite the morphologic overlap, we now know that the fibroblast foci of UIP/IPF differ from the Masson bodies of organizing pneumonia in several important ways including fibroblast/myofibroblast phenotype, rates of fibroblast/myofibroblast apoptosis, modulation of extracellular matrix deposition, and extent of neovascularization (2). Differences in the character and extent of reepithelialization may play a pivotal role in determining why "fibroblast foci" of UIP/IPF resolve into a scar while the Masson bodies of organizing pneumonia disappear without a trace. Disordered reepithelialization in UIP/IPF has previously been linked to upregulation of epithelial cell apoptosis and impaired adhesion to damaged basement membranes (2, 8, 11).

In this issue of the Journal (pp. 27–33), Lappi-Blanco and colleagues contrast and compare reepithelialization at sites of acute injury in lung biopsies from patients with UIP/IPF and cryptogenic organizing pneumonia, lending further support to a model of abnormal wound repair in UIP/IPF (12). Using immunohistochemical techniques, fewer epithelial cells were demonstrated as a percentage of affected surface area in fibroblast foci compared with Masson bodies. The differences were statistically significant, but there was a wide range in each group indicating that key differences are as likely to be qualitative as they are quantitative. Indeed they identified greater degrees of epithelial "disarray" in the population of hyperplastic epithelial cells in UIP/IPF as evidenced by variation in cytomorphology, layering of cells at the leading edge of regeneration, exfoliation of epithelial cells, and a greater degree of heterogeneity within and between acute lung injury sites. Furthermore, immunoreactivity for surfactant associated protein A was limited to hyperplastic epithelium associated with fibroblast foci in UIP/IPF, suggesting that pneumocytes are the primary players in UIP/IPF while bronchiolar epithelium or more primitive stem cells participate in cryptogenic organizing pneumonia. This difference is intuitively attractive given that UIP/IPF affects the distal pulmonary acinus and cryptogenic organizing pneumonia is distinctly bronchiolocentric.

Despite quantitative and qualitative differences between populations of "reparative" epithelial cells in UIP/IPF and cryptogenic organizing pneumonia, Lappi-Blanco and coworkers demonstrate no differences in synthesis or expression of the {gamma}2 chain of laminin-5 (12). Laminin-5 {gamma}2 chain is an important candidate molecule for understanding the efficiency and success of wound repair in the lung. As summarized by the authors, it is highly expressed in fetal respiratory epithelium and is also present in the subepithelial basement membrane of adult lungs. The function of laminin-5 {gamma}2 chain varies with the stage of processing, allowing it to promote not only cell adhesion but also cell migration in remodeling tissues. The authors speculate that differences in matrix metalloproteinases and their inhibitors, previously demonstrated in UIP/IPF (13), may modulate functional differences in laminin 5 {gamma}2 chain not appreciable in purely quantitative studies. Other cofactors also deserve vigorous investigation. For example, integrin {alpha}3ß1 plays an important role in determining the incorporation of laminin-5 into its proper higher order structure within the extracellular matrix, and its activation is critical for epithelial cell spreading/migration on laminin-5 (14, 15).

The role of respiratory epithelium in initiating and maintaining abnormal wound repair remains an elusive but promising area of study with the potential to impact future treatment strategies. Discovery of novel therapies may hinge on a greater understanding of genetically determined differences in recovery rather than identifying a specific trigger (etiology) for epithelial injury/activation. After all, a fire requires not only an inciting spark but also a flammable substrate before it can prove destructive. In IPF, respiratory epithelium may function as both.

FOOTNOTES

Conflict of Interest Statement: J.L.M. has no declared conflict of interest; M.S. has no declared conflict of interest.

REFERENCES

  1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646–664.[Free Full Text]
  2. Selman M, King T Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136–151.[Abstract/Free Full Text]
  3. Katzenstein A-L. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. Hum Pathol 1985;16:1015–1024.[Medline]
  4. Myers J, Katzenstein A-L. Ultrastructural evidence of alveolar epithelial injury in idiopathic bronchiolitis obliterans-organizing pneumonia. Am J Pathol 1988;132:102–109.[Abstract]
  5. Myers J, Katzenstein A-L. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest 1988;94:1309–1311.[Abstract/Free Full Text]
  6. Kuhn C III, Boldt J, King T Jr, Crouch E, Vartio T, McDonald J. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989;140:1693–1703.[Medline]
  7. Morishima Y, Nomura A, Uchida Y, Noguchi Y, Sakamoto T, Isii Y, Goto Y, Masuyama K, Zhang M, Hirano K, et al. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol 2001;24:1–11.[Abstract/Free Full Text]
  8. Uhal BD, Joshi I, Mundle S, Raza A, Pardo A, Selman M. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol 1995;269:L819–L828.
  9. Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis: tying loose ends. Am J Respir Cell Mol Biol 2003;29:S93–S97.
  10. Fang K. Mesenchymal regulation of alveolar repair in pulmonary fibrosis. Am J Respir Cell Mol Biol 2000;23:142–145.[Free Full Text]
  11. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N. p21Waf1/Cip1/Ski1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996;154:477–483.[Abstract]
  12. Lappi-Blanco E, Kaarteenaho-Wiik R, Salo S, Sormunen R, Määttä M, Autio-Harmainen H, Soini Y, Pääkkö P. Laminin-5 {gamma}2 chain in cryptogenic organizing pneumonia and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169:27–33.[Abstract/Free Full Text]
  13. Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, Pardo A. TIMP-1, -2, -3 and -4 in idiopathic pulmonary fibrosis: a prevailing non degradative lung microenvironment? Am J Physiol 2000;279:L562–L574.
  14. deHart GW, Healy KE, Jones JC. The role of alpha3beta1 integrin in determining the supramolecular organization of laminin-5 in the extracellular matrix of keratinocytes. Exp Cell Res 2003;283:67–79.[CrossRef][Medline]
  15. Santoro MM, Gaudino G, Marchisio PC. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Dev Cell 2003;5:257–271.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. M. Kelly, R. Leigh, S. E. Gilpin, E. Cheng, G. E. M. Martin, K. Radford, G. Cox, and J. Gauldie
Cell-specific Gene Expression in Patients with Usual Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 557 - 565.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J-F. Cordier
Cryptogenic organising pneumonia.
Eur. Respir. J., August 1, 2006; 28(2): 422 - 446.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. A. Forrest, D. M. Murphy, C. Ward, D. Jones, G. E. Johnson, L. Archer, F. K. Gould, T. E. Cawston, J. L. Lordan, and P. A. Corris
Primary airway epithelial cell culture from lung transplant recipients
Eur. Respir. J., December 1, 2005; 26(6): 1080 - 1085.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, J. L.
Right arrow Articles by Selman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, J. L.
Right arrow Articles by Selman, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society